De Burlo Group Inc Johnson & Johnson Transaction History

De Burlo Group Inc

$808 Million
Q3 2024

A detailed history of De Burlo Group Inc transactions in Johnson & Johnson stock. As of the latest transaction made, De Burlo Group Inc holds 1,333 shares of JNJ stock, worth $194,418. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,333

Holding current value

$194,418

% of portfolio

0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$145.48 - $167.38 $193,924 - $223,117	1,333 New	1,333 $216,000
Q1 2024 May 13, 2024	SELL	$155.22 - $162.74 $1.35 Million - $1.41 Million	-8,669 Reduced 83.34%	1,733 $274,000
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $101,237 - $113,412	-650 Reduced 5.88%	10,402 $1.62 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $20,682 - $22,258	-134 Reduced 1.2%	11,052 $1.83 Million
Q1 2023 May 12, 2023	SELL	$151.05 - $180.26 $13.5 Million - $16.2 Million	-89,700 Reduced 88.91%	11,186 $1.73 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $1.47 Million - $1.65 Million	-9,160 Reduced 8.32%	100,886 $17.8 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $15.5 Million - $17.2 Million	95,977 Added 682.19%	110,046 $18 Million
Q2 2022 Aug 11, 2022	BUY	$168.19 - $186.01 $444,021 - $491,066	2,640 Added 23.1%	14,069 $2.5 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $31,627 - $35,918	-200 Reduced 1.72%	11,429 $2.03 Million
Q4 2021 Jan 28, 2022	BUY	$155.93 - $173.01 $74,690 - $82,871	479 Added 4.3%	11,629 $1.99 Million
Q2 2021 Aug 05, 2021	BUY	$159.48 - $171.07 $1.32 Million - $1.42 Million	8,276 Added 287.96%	11,150 $1.84 Million
Q1 2021 May 06, 2021	BUY	$153.07 - $170.48 $122,456 - $136,384	800 Added 38.57%	2,874 $472,000
Q4 2020 Feb 05, 2021	BUY	$137.11 - $157.38 $10,146 - $11,646	74 Added 3.7%	2,074 $326,000
Q3 2020 Nov 05, 2020	BUY	$140.38 - $153.83 $28,076 - $30,766	200 Added 11.11%	2,000 $298,000
Q1 2020 May 07, 2020	SELL	$111.14 - $153.99 $7,890 - $10,933	-71 Reduced 3.79%	1,800 $236,000
Q4 2019 Feb 06, 2020	BUY	$127.5 - $146.44 $9,052 - $10,397	71 Added 3.94%	1,871 $273,000
Q3 2019 Nov 07, 2019	SELL	$126.95 - $142.14 $25,390 - $28,427	-200 Reduced 10.0%	1,800 $233,000
Q1 2019 May 09, 2019	SELL	$125.72 - $139.79 $886,326 - $985,519	-7,050 Reduced 77.9%	2,000 $279,000
Q3 2018 Nov 08, 2018	SELL	$121.58 - $142.88 $194,528 - $228,608	-1,600 Reduced 15.02%	9,050 $1.25 Million
Q2 2018 Aug 10, 2018	SELL	$119.4 - $131.76 $11,940 - $13,176	-100 Reduced 0.93%	10,650 $1.29 Million
Q1 2018 May 03, 2018	SELL	$125.1 - $148.14 $6.53 Million - $7.73 Million	-52,200 Reduced 82.92%	10,750 $1.38 Million
Q4 2017 Feb 08, 2018	BUY	$131.22 - $143.62 $2.48 Million - $2.71 Million	18,900 Added 42.91%	62,950 $8.8 Million
Q3 2017 Nov 02, 2017	BUY	$129.47 - $135.38 $5.7 Million - $5.96 Million	44,050	44,050 $5.73 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of De Burlo Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on De Burlo Group Inc with notifications on news.

Account